Literature DB >> 21155127

Expanding the horizons of PARP inhibitors.

Teresa Villanueva.   

Abstract

Entities:  

Year:  2010        PMID： 21155127     DOI： 10.1038/nrc2971

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.

Authors:  Norman Chan; Isabel M Pires; Zuzana Bencokova; Carla Coackley; Kaisa R Luoto; Nirmal Bhogal; Minalini Lakshman; Ponnari Gottipati; F Javier Oliver; Thomas Helleday; Ester M Hammond; Robert G Bristow
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701
  1 in total
  3 in total

1.  Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".

Authors:  Mateusz Rytelewski; Peter J Ferguson; Saman Maleki Vareki; Rene Figueredo; Mark Vincent; James Koropatnick
Journal:  Mol Ther Nucleic Acids       Date:  2013-03-12       Impact factor: 10.183

2.  Drug treatment of cancer cell lines: a way to select for cancer stem cells?

Authors:  Ilaria Chiodi; Cristina Belgiovine; Francesca Donà; A Ivana Scovassi; Chiara Mondello
Journal:  Cancers (Basel)       Date:  2011-03-04       Impact factor: 6.639

3.  Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2.

Authors:  Mateusz Rytelewski; Saman Maleki Vareki; Lingegowda S Mangala; Larissa Romanow; Dahai Jiang; Sunila Pradeep; Christian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Rene Figueredo; Peter J Ferguson; Mark Vincent; Anil K Sood; James D Koropatnick
Journal:  Oncotarget       Date:  2016-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.